Literature DB >> 32707604

Dysregulation in B-cell responses and T follicular helper cell function in ADA2 deficiency patients.

Francesca Schena1, Federica Penco1, Stefano Volpi1,2, Claudia Pastorino1, Roberta Caorsi3, Francesca Kalli4, Daniela Fenoglio4,5, Annalisa Salis6, Arinna Bertoni1, Ignazia Prigione1, Paola Bocca1, Antonella Insalaco7, Fabrizio De Benedetti7, Francesca Antonini8, Alice Grossi9, Sara Signa1,2, Gianluca Damonte6, Isabella Ceccherini9, Gilberto Filaci4,10, Elisabetta Traggiai11, Marco Gattorno1,3.   

Abstract

Adenosine deaminase 2 deficiency (DADA2) is an autoinflammatory disease characterized by inflammatory vasculopathy, early strokes associated often with hypogammaglobulinemia. Pure red cell aplasia, thrombocytopenia, and neutropenia have been reported. The defect is due to biallelic loss of function of ADA2 gene, coding for a protein known to regulate the catabolism of extracellular adenosine. We therefore investigated immune phenotype and B- and T-cell responses in 14 DADA2 patients to address if ADA2 mutation affects B- and T-cell function. Here, we show a significant decrease in memory B cells, in particular class switch memory, and an expansion of CD21low B cells in DADA2 patients. In vitro stimulated B lymphocytes were able to secrete nonfunctional ADA2 protein, suggesting a cell intrinsic defect resulting in an impairment of B-cell proliferation and differentiation. Moreover, CD4+ and CD8+ T cells were diminished; however, the frequency of circulating T follicular helper cells was significantly increased but they had an impairment in IL-21 production possibly contributing to an impaired B cell help. Our findings suggest that ADA2 mutation could lead to a B-cell intrinsic defect but also to a defective Tfh cell function, which could contribute to the immunodeficient phenotype reported in DADA2 patients.
© 2020 Wiley-VCH GmbH.

Entities:  

Keywords:  Adenosine deaminase 2; B cell; Follicular helper T cells; Hypogammaglobulinemia; Immunodeficiency

Mesh:

Substances:

Year:  2020        PMID: 32707604     DOI: 10.1002/eji.202048549

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  12 in total

Review 1.  Mechanisms of vascular inflammation in deficiency of adenosine deaminase 2 (DADA2).

Authors:  Pui Y Lee; Ivona Aksentijevich; Qing Zhou
Journal:  Semin Immunopathol       Date:  2022-02-17       Impact factor: 9.623

Review 2.  Deficiency of Human Adenosine Deaminase Type 2 - A Diagnostic Conundrum for the Hematologist.

Authors:  Rakesh Kumar Pilania; Aaqib Zaffar Banday; Saniya Sharma; Rajni Kumrah; Vibhu Joshi; Sathish Loganathan; Manpreet Dhaliwal; Ankur Kumar Jindal; Pandiarajan Vignesh; Deepti Suri; Amit Rawat; Surjit Singh
Journal:  Front Immunol       Date:  2022-05-03       Impact factor: 8.786

3.  The Spectrum of the Deficiency of Adenosine Deaminase 2: An Observational Analysis of a 60 Patient Cohort.

Authors:  Karyl S Barron; Ivona Aksentijevich; Natalie T Deuitch; Deborah L Stone; Patrycja Hoffmann; Ryan Videgar-Laird; Ariane Soldatos; Jenna Bergerson; Camilo Toro; Cornelia Cudrici; Michele Nehrebecky; Tina Romeo; Anne Jones; Manfred Boehm; Jennifer A Kanakry; Dimana Dimitrova; Katherine R Calvo; Hawwa Alao; Devika Kapuria; Gil Ben-Yakov; Dominique C Pichard; Londa Hathaway; Alessandra Brofferio; Elisa McRae; Natalia Sampaio Moura; Oskar Schnappauf; Sofia Rosenzweig; Theo Heller; Edward W Cowen; Daniel L Kastner; Amanda K Ombrello
Journal:  Front Immunol       Date:  2022-01-10       Impact factor: 7.561

4.  Intrinsic Defects in B Cell Development and Differentiation, T Cell Exhaustion and Altered Unconventional T Cell Generation Characterize Human Adenosine Deaminase Type 2 Deficiency.

Authors:  Stuart G Tangye; Isabelle Meyts; Jin Yan Yap; Leen Moens; Ming-Wei Lin; Alisa Kane; Anthony Kelleher; Catherine Toong; Kathy H C Wu; William A Sewell; Tri Giang Phan; Georgina E Hollway; Karen Enthoven; Paul E Gray; Jose Casas-Martin; Carine Wouters; Lien De Somer; Michael Hershfield; Giorgia Bucciol; Selket Delafontaine; Cindy S Ma
Journal:  J Clin Immunol       Date:  2021-10-17       Impact factor: 8.317

5.  Lentiviral Mediated ADA2 Gene Transfer Corrects the Defects Associated With Deficiency of Adenosine Deaminase Type 2.

Authors:  Ying Hong; Marina Casimir; Benjamin C Houghton; Fang Zhang; Barbara Jensen; Ebun Omoyinmi; Robert Torrance; Charalampia Papadopoulou; Michelle Cummins; Marion Roderick; Adrian J Thrasher; Paul A Brogan; Despina Eleftheriou
Journal:  Front Immunol       Date:  2022-04-22       Impact factor: 8.786

Review 6.  Adenosine Deaminase 2 Deficiency (DADA2): A Crosstalk Between Innate and Adaptive Immunity.

Authors:  Sara Signa; Arinna Bertoni; Federica Penco; Roberta Caorsi; Alessia Cafaro; Giuliana Cangemi; Stefano Volpi; Marco Gattorno; Francesca Schena
Journal:  Front Immunol       Date:  2022-07-11       Impact factor: 8.786

Review 7.  Allogeneic Hematopoietic Cell Transplantation for Patients With Deficiency of Adenosine Deaminase 2 (DADA2): Approaches, Obstacles and Special Considerations.

Authors:  Hasan Hashem; Dimana Dimitrova; Isabelle Meyts
Journal:  Front Immunol       Date:  2022-07-07       Impact factor: 8.786

8.  T cells and monocytes: A dangerous liaison in adenosine deaminase 2 deficiency.

Authors:  Cristina Mesa-Nuñez; Alessandra Mortellaro
Journal:  J Leukoc Biol       Date:  2022-02       Impact factor: 6.011

9.  Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency.

Authors:  Federica Barzaghi; Maria Pia Cicalese; Matteo Zoccolillo; Immacolata Brigida; Matteo Barcella; Ivan Merelli; Claudia Sartirana; Monica Zanussi; Valeria Calbi; Maria Ester Bernardo; Francesca Tucci; Maddalena Migliavacca; Fabio Giglio; Matteo Doglio; Daniele Canarutto; Francesca Ferrua; Giulia Consiglieri; Giulia Prunotto; Francesco Saettini; Sonia Bonanomi; Patrizia Rovere-Querini; Giulia Di Colo; Tatiana Jofra; Georgia Fousteri; Federica Penco; Marco Gattorno; Michael S Hershfield; Lucia Bongiovanni; Maurilio Ponzoni; Sarah Marktel; Raffaella Milani; Jacopo Peccatori; Fabio Ciceri; Alessandra Mortellaro; Alessandro Aiuti
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786

10.  Plasma Adenosine Deaminase (ADA)-1 and -2 Demonstrate Robust Ontogeny Across the First Four Months of Human Life.

Authors:  Oludare A Odumade; Alec L Plotkin; Jensen Pak; Olubukola T Idoko; Matthew A Pettengill; Tobias R Kollmann; Al Ozonoff; Beate Kampmann; Ofer Levy; Kinga K Smolen
Journal:  Front Immunol       Date:  2021-05-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.